| Title |
Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children
|
|---|---|
| Published in |
Cochrane database of systematic reviews, November 2021
|
| DOI | 10.1002/14651858.cd013757.pub2 |
| Pubmed ID | |
| Authors |
Luis Garegnani, Lea Styrmisdóttir, Pablo Roson Rodriguez, Camila Micaela Escobar Liquitay, Ignacio Esteban, Juan Va Franco |
X Demographics
The data shown below were collected from the profiles of 37 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 5 | 14% |
| Sweden | 3 | 8% |
| Colombia | 2 | 5% |
| France | 1 | 3% |
| Spain | 1 | 3% |
| United Kingdom | 1 | 3% |
| Chile | 1 | 3% |
| Germany | 1 | 3% |
| Turkey | 1 | 3% |
| Other | 2 | 5% |
| Unknown | 19 | 51% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 31 | 84% |
| Scientists | 5 | 14% |
| Practitioners (doctors, other healthcare professionals) | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 232 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 232 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 15 | 6% |
| Student > Master | 15 | 6% |
| Other | 13 | 6% |
| Student > Bachelor | 13 | 6% |
| Unspecified | 9 | 4% |
| Other | 37 | 16% |
| Unknown | 130 | 56% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 45 | 19% |
| Unspecified | 11 | 5% |
| Nursing and Health Professions | 8 | 3% |
| Immunology and Microbiology | 6 | 3% |
| Agricultural and Biological Sciences | 4 | 2% |
| Other | 22 | 9% |
| Unknown | 136 | 59% |
Attention Score in Context
This research output has an Altmetric Attention Score of 70. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 April 2024.
All research outputs
#628,052
of 25,986,827 outputs
Outputs from Cochrane database of systematic reviews
#1,073
of 13,170 outputs
Outputs of similar age
#14,044
of 418,488 outputs
Outputs of similar age from Cochrane database of systematic reviews
#16
of 168 outputs
Altmetric has tracked 25,986,827 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,170 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 33.3. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 418,488 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 168 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.